Mangoceuticals

MGRX · NASDAQ

$0.30+$0.0199 (+7.10%)TodayMarket closed ·
Prev close $0.2801

Who owns MGRX

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 15.8% of MGRX’s shares.

  • Cohen (Jacob D.)7.7%
  • Citadel Advisors LLC2.0%
  • XTX Markets LLC1.1%
  • Geode Capital Management, L.L.C.0.9%
  • Next 6 largest institutions4.1%
  • All other shareholders84.2%
Top institutional holders of MGRX
HolderShares% of shares
Cohen (Jacob D.)1.31M7.66%
Citadel Advisors LLC338.96K1.97%
XTX Markets LLC186.26K1.08%
Geode Capital Management, L.L.C.156.24K0.91%
Ikarian Capital LLC138.15K0.80%
Myers (Kenny)136.67K0.80%
D'Alessio (Lorraine Pamela)136.67K0.80%
Vanguard Capital Management, LLC123.04K0.72%
Johnston (Eugene M)120.00K0.70%
Vanguard Fiduciary Trust Co57.16K0.33%

Largest mutual fund holders

Top mutual fund holders of MGRX
HolderShares% of shares
Vanguard Extended Market Index Fund123.04K0.72%
Fidelity Extended Market Index Fund76.53K0.45%
Fidelity NASDAQ Composite Index Fund44.40K0.26%
Fidelity Series Total Market Index Fund14.44K0.08%
Fidelity Total Market Index Fund12.61K0.07%

Insider trades

Form 4 filings by officers, directors and large holders

Insiders made no open-market buys or sales of MGRX in the last 6 months.

Latest MGRX insider transactions
InsiderTypeSharesValue
Cohen Jacob D.Gift2.00M—
Cohen Jacob D.Gift2.00M—
Hamilton Alex P.Award100.00K—
Cohen Jacob D.Award2.00M—
JOHNSTON EUGENE MAward100.00K—

Short interest

Settled Sep 30, 2026

Shares short
438.79K
Days to cover
1.00
% of shares outstanding
2.56%
Average daily volume
655.31K
Change since last report
−15.8%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.